These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen). Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860 [TBL] [Abstract][Full Text] [Related]
30. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome. Heestermans AA; van Werkum JW; Zwart B; van der Heyden JA; Kelder JC; Breet NJ; van't Hof AW; Dambrink JH; Koolen JJ; Brueren BR; Zijlstra F; ten Berg JM J Thromb Haemost; 2010 Nov; 8(11):2385-93. PubMed ID: 20831622 [TBL] [Abstract][Full Text] [Related]
31. No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting. Sibbing D; Koch W; Massberg S; Byrne RA; Mehilli J; Schulz S; Mayer K; Bernlochner I; Schömig A; Kastrati A Eur Heart J; 2011 Jul; 32(13):1605-13. PubMed ID: 21527445 [TBL] [Abstract][Full Text] [Related]
32. Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel. Raposeiras-Roubín S; Abu-Assi E; D'Ascenzo F; Fernández-Barbeira S; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Quadri G; Rognoni A; Boccuzzi G; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Flores Blanco P; Garay A; Varbella F; Tommassini F; Caneiro Queija B; Cobas Paz R; Cespón Fernández M; Muñoz Pousa I; Gallo D; Morbiducci U; Domínguez-Rodríguez A; Baz-Alonso JA; Valdés M; Cequier Á; Gaita F; Alexopoulos D; Íñiguez-Romo A Rev Esp Cardiol (Engl Ed); 2019 Apr; 72(4):298-304. PubMed ID: 29954720 [TBL] [Abstract][Full Text] [Related]
33. Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry. Nakamura M; Yamagishi M; Ueno T; Hara K; Ishiwata S; Itoh T; Hamanaka I; Wakatsuki T; Sugano T; Kawai K; Kimura T Cardiovasc Interv Ther; 2013 Apr; 28(2):162-9. PubMed ID: 23233418 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes. Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655 [TBL] [Abstract][Full Text] [Related]
35. Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study. Charlot M; Nielsen LH; Lindhardsen J; Ahlehoff O; Olsen AM; Hansen ML; Hansen PR; Madsen JK; Køber L; Gislason GH; Torp-Pedersen C Eur Heart J; 2012 Oct; 33(20):2527-34. PubMed ID: 22798561 [TBL] [Abstract][Full Text] [Related]
36. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy. Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050 [TBL] [Abstract][Full Text] [Related]
38. Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial. Camaro C; Damen SA; Brouwer MA; Kedhi E; Lee SW; Verdoia M; Barbieri L; Rognoni A; van T Hof AW; Ligtenberg E; de Boer MJ; Suryapranata H; De Luca G Am Heart J; 2016 Aug; 178():37-44. PubMed ID: 27502850 [TBL] [Abstract][Full Text] [Related]
39. Platelet function monitoring for stent thrombosis in critically III patients with an acute Coronary syndrome. Tilemann L; Mohr SK; Preusch M; Chorianopoulos E; Giannitsis E; Katus HA; Müller OJ J Interv Cardiol; 2018 Jun; 31(3):277-283. PubMed ID: 29214676 [TBL] [Abstract][Full Text] [Related]
40. Early stent thrombosis in patients undergoing primary coronary stenting for acute myocardial infarction: incidence, a simple risk score, and prognosis. Ergelen M; Uyarel H; Osmonov D; Ayhan E; Akkaya E; Soylu O; Orhan AL; Sayar N; Bozbay M; Turer A; Yildirim E; Yekeler I Clin Appl Thromb Hemost; 2010 Feb; 16(1):33-41. PubMed ID: 19736213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]